Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples